115 6 DELIRIUM | PART THREE Table 1. Baseline characteristics. DOS negative N=94 (SD or %) DOS positive N=93 (SD or %) p Age 60 (12.9) 68 (11.1) <.001 Gender Male 58 (62%) 66 (71%) Female 36 (38%) 27 (29%) .180 Tumor type Gastro-intestinal 40 (43%) 28 (30%) Breast 6 (6%) 6 (7%) Genito-urethral 23 (25%) 29 (32%) Skin 4 (4%) 8 (9%) Lung 0 3 (3%) Head&neck 5 (5%) 2 (2%) Brain 0 2 (2%) Sarcoma 4 (4%) 1 (1%) Hematological 1 (1%) 9 (10%) Other 11 (12%) 5 (5%) .484 Brain metastasis No 89 (95%) 87 (94%) Yes 5 (5%) 6 (6%) .767 Abbreviations: DOS, Delirium Observational Scale; SD, standard deviation No statistically significant differences were found except for age; DOS positive patients, who screened positive for delirium with a score ≥ 3 on this scale, tended to be older than DOS negative patients. Table 2. DOS vs. DRS-R-98. Distribution of the results of the DOS and DRS-R-98 scores. DRS-R-98 no delirium (<17.75) DRS-R-98 delirium (≥17.75) Total DOS no delirium (<3) 94 0 94 DOS delirium (≥3) 5 88 93 Total 99 88 Abbreviations: DOS, Delirium Observational Scale; DRS-R-98, Delirium Rating Scale Revised 98
RkJQdWJsaXNoZXIy MjY0ODMw